MaxCyte (LON:MXCT) Shares Cross Below 50-Day Moving Average – Should You Sell?

MaxCyte, Inc. (LON:MXCT) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 346 ($4.35) and traded as low as GBX 264 ($3.32). MaxCyte shares last traded at GBX 264 ($3.32), with a volume of 29,582 shares.

MaxCyte Trading Down 2.6 %

The stock has a market cap of £348.49 million, a PE ratio of -9.67 and a beta of 1.13. The company has a current ratio of 9.81, a quick ratio of 14.38 and a debt-to-equity ratio of 8.59. The firm has a fifty day simple moving average of GBX 344.76 and a two-hundred day simple moving average of GBX 313.89.

MaxCyte Company Profile

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients.